The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
NIAID strategic plan detailed COVID-19 research priorities
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
Oxford University COVID-19 vaccine began human trial stage
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
Oxford University Government began collaboration to track Covid-19 in UK population launched
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
AstraZeneca and Saint Lukeﾒs Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patients
On Apr. 23, 2020, AstraZeneca and and Saint Lukeﾒs Mid America Heart Institute initiated a randomised, global Phase…
Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemic
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
Key nose cells identified as likely COVID-19 entry points
On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…
TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patients
On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft…
Yale launched clinical trial for drug to treat severe COVID-19 patients
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research
On Apr. 23, 2020, BioSig Technologies announced that an article titled, ﾓThe IMPDH inhibitor merimepodib has similar antiviral…
Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facility
On Apr. 23, 2020, Catalent announced the completion of its $14 million expansion to increase the biologics packaging…
Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
CHF Solutions shipped first commercial orders of Aquadex SmartFlow system to Austria
On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial
On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…
Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
Roswell Park and Partners announced new Western New York Immunogenomic COVID-19 Study
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
Daxor awarded $1.1 million contract from US Department of Defense for rapid portable blood volume analyzer
On Apr. 23, 2020, Daxor Corp. announced that the U.S. Department of Defense (DOD) had awarded the Company…
The USDA confirmed COVID-19 in two pet cats in New York
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19
On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…
BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnostic
On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…
SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
The FDA approved new therapy for triple negative breast cancer
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…
Quidel’s Lyra direct SARS-CoV-2 assay submitted for Emergency Use Authorization for molecular detection of COVID-19
On Apr. 22, 2020, Quidel announced it has applied for an Emergency Use Authorization (EUA) for the Lyraﾮ…
Tyson Foods indefinitely suspended operations in Waterloo, Iowa
On Apr. 22, 2020, Tyson Fresh Meats, the beef and pork subsidiary of Tyson Food, planned to indefinitely…
Researchers identified cells likely targeted by COVID-19 virus
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchers
On Apr. 22, 2020, Engineers at the McKelvey School of Engineering at Washington University in St. Louis announced…
LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizations
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…